LivsMed리브스메드
491000 · KOSDAQ · ₩491000 · 리브스메드
₩40,450▼ ₩3,200 (7.33%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩51B |
| Cost of sales | ₩22B |
| Gross profit | ₩30B |
| Operating income | −₩23B |
| Net income | −₩23B |
| Net income to shareholders | −₩23B |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩202B |
| Current assets | ₩175B |
| Cash and equivalents | ₩11B |
| Total liabilities | ₩21B |
| Current liabilities | ₩14B |
| Borrowings | ₩3B |
| Total equity | ₩181B |
| Shareholders' equity | ₩181B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | −₩35B |
| Capital spending | ₩7.2B |
| Free cash flow | −₩42B |
Consolidated where available. Amounts in won.
Also known as: LivsMed / 리브스메드 / 491000 / KRX:491000
Source: KRX statistical information